Standard BioTools Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureOct 5 →Insiders8 insiders bought $14.4M in 15 open-market buys. No sales.→PeersClosest companies: PACB, TWST, TXG→
From the filings
Figures
- Revenue
- $84.6Mlast 12 months
- Net income
- $84.9Mlast 12 months
- Operating cash flow
- −$90.7Mlast 12 months
- Cash and equivalents
- $270.0Mat the last balance sheet
- Shares outstanding
- 392.1M shareson issue